Takeda Oncology
Ruth Williams is a seasoned professional in the field of scientific communications, currently serving as the Scientific Communications Group Lead for Solid Tumors at Takeda Oncology since November 2008. Ruth's career at Takeda has involved progressive leadership roles, including Director of Medical Communications for the Oncology Pipeline and Associate Director of Medical Communications, as well as various positions in product information. Prior to joining Takeda, Ruth gained valuable experience as a Research Scientist and Postdoctoral Fellow at the Massachusetts Institute of Technology from July 2002 to November 2008. Ruth holds an AB with honors in Biology from Brown University and a Ph.D. in Biology from UC San Diego.
This person is not in any teams
This person is not in any offices
Takeda Oncology
21 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.